Dataset from The Efficacy and Safety of Once-Weekly, Subcutaneous Dulaglutide Compared to Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Mellitus on Metformin and/or a Sulfonylurea
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00007433
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to examine if once-weekly dulaglutide is efficient and safe
compared to once-daily insulin glargine in participants with type 2 diabetes mellitus who
have inadequate glycemic control with 1 or 2 oral antihyperglycemic medications (OAM)
(metformin and/or a sulfonylurea), in addition to any healthy lifestyle changes recommended
by their healthcare providers.
创建时间：
2025-12-08
